UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042086
Receipt number R000047989
Scientific Title Safety evaluation of children's skin care products for children with dry skin or mild atopic dermatitis
Date of disclosure of the study information 2020/10/26
Last modified on 2023/11/29 10:09:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety evaluation of children's skin care products for children with dry skin or mild atopic dermatitis

Acronym

Safety evaluation of children's skin care products

Scientific Title

Safety evaluation of children's skin care products for children with dry skin or mild atopic dermatitis

Scientific Title:Acronym

Safety evaluation of children's skin care products

Region

Japan


Condition

Condition

Dry skin, mild atopic dermatitis

Classification by specialty

Pediatrics Dermatology Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to evaluate the safety of children's skin care products after 4 weeks of use, for children aged 4 to 10 with dry skin or mild atopic dermatitis.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Presence or absence of adverse events by severity for which a causal relationship to the test cosmetics cannot be denied after use of the test cosmetics

Key secondary outcomes

1) Existence of all adverse events by severity
2) Skin examination findings before, 2 and 4 weeks after the use of the test cosmetic, and at the appearance of a rash
3) Before use of test cosmetics, after 2 weeks and after 4 weeks stratum corneum water content, transepidermal water loss, skin pH
4) Skin components by Raman spectroscopy before, 2 and 4 weeks after use of test cosmetics: Moisture content, natural moisturizing factor, cholesterol, lactic acid, uric acid, ceramide


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Test item:Moisturizing products, Cleaning products.
Dose:Moisturizing products, Twice a day. Cleaning products, Once a day.
Usage:Moisturizing products, Apply in the morning and evening (after bathing) to the entire body, including the face, excluding the head.
Cleaning products,
Use your hands to spread the hidden parts such as the Body and back, neck and crotch, neck and limbs, and the back of ears so that there is no wash residue. Wash your face with foam and rinse with a soft water pressure shower.
Period:4 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

4 years-old <=

Age-upper limit

11 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patients with mild to moderate dryness diagnosed by a dermatologist, or those diagnosed with mild atopic dermatitis (Those who have been diagnosed with atopic dermatitis according to the U.K. Working Party diagnostic criteria and have an EASI score of 7.0 or less.)
2)Patients aged 4 to 10 at the time of obtaining consent
3)Patients who have received sufficient explanation before participating in this test, and who have obtained the free will of the consent of the substitute after obtaining sufficient understanding.

Key exclusion criteria

1)Persons diagnosed with moderate or higher atopic dermatitis
2)Those who may have allergic symptoms due to the tested cosmetic ingredients
3)Those who are Caucasian or Black
4)Those who participate in other clinical trials
5)In addition, if the principal investigator or co-investigators determine that it is inappropriate

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazue
Middle name
Last name Yoshida

Organization

National Center for Child Health and Development

Division name

Division of Dermatology

Zip code

157-8535

Address

2-10-1,Okura,Setagayaku,Tokyo 157-8535

TEL

03-3416-0181

Email

skin_research@ncchd.go.jp


Public contact

Name of contact person

1st name Risa
Middle name
Last name Fukuda

Organization

National Center for Child Health and Development

Division name

Division of Dermatology

Zip code

157-8535

Address

2-10-1,Okura,Setagayaku,Tokyo 157-8535

TEL

03-3416-0181

Homepage URL


Email

skin_research@ncchd.go.jp


Sponsor or person

Institute

National Center for Child health and Development

Institute

Department

Personal name



Funding Source

Organization

Natural Science Co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Child health and Development

Address

2-10-1,Okura,Setagayaku,Tokyo 157-8535

Tel

03-3416-0181

Email

rinri@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立研究開発法人 国立成育医療研究センター (東京都)
National Center for Child Health and Development (Tokyo)


Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 09 Month 15 Day

Date of IRB

2020 Year 10 Month 19 Day

Anticipated trial start date

2020 Year 10 Month 29 Day

Last follow-up date

2023 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 10 Month 12 Day

Last modified on

2023 Year 11 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047989


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name